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CHAPTER I 
 
 
INTRODUCTION 
 
Taylorella equigenitalis is a microaerophilic gram negative coccobacillus that is 
the causative agent of equine contagious metritis (CEM).  Originally named Haemophilus 
equigenitalis, the contagious equine metritis organism (CEMO) was initially reported in 
England (Crowhurst 1977), Ireland (Hughes, Bryden et al. 1978), and Australia in 1977 
(Hazard, Hughes et al. 1979), as a transmissible venereal disease in equids.   Over the 
next two years, T. equigenitalis was isolated in Kentucky, France, Germany, Belgium, 
and Missouri in various horse breeds (Powell 1981).  Since 1978, the United States has 
encountered additional CEM outbreaks in Missouri (1979), Kentucky (1982),  Wisconsin 
in 2006 and most recently rediscovery of CEM in Kentucky  in 2008 (APHIS 2009).  
Since the discovery of T. equigenitalis in December of 2008, 1,001 horses have 
been exposed in the United States, including 23 positive stallions and 5 positive mares.  
Forty eight states have been involved since December 2008, and the origin for this latest 
incursion of the disease is still under investigation (APHIS 2010).  The National 
Veterinary Services Laboratory performed antimicrobial susceptibility testing and pulsed-
field gel electrophoresis (PFGE) on the T. equigenitalis isolates from this occurrence in 
the United States.  Of the isolates tested, 26 samples were streptomycin resistant with 
matching banding patterns between samples, but the PFGE profiles did not match those 
of strains isolated in 1978 and 2006 (APHIS 2009). 
The clinical signs of CEM in mares vary from copious amounts of mucopurulent 
vaginal discharge, vaginitis, cervicitis, endometritis, and extreme vaginal/cervical 
hyperemia to mild cervicitis with minimal, sometimes non-existent uterine discharge 
(Swerczek 1978; Powell 1981; APHIS 2009) .  These clinical signs are apparent from 2 
days to 2 weeks post-breeding and can persist for days to weeks. Mares commonly return 
to estrus within 1-2 weeks of infection (Powell 1981), but rarely abortion can occur 
(APHIS 2009).   In mares, the organism can be cultured from the clitoral fossa and sinus, 
cervix, endometrium, and in some cases the vaginal discharge (APHIS 2009). While 
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some mares make spontaneous clinical recovery (Swerczek 1978a), many become 
asymptomatic carriers, harboring the organism in the clitoral fossa and sinuses.  Some of 
these mares can be difficult to detect and often take several treatments to clear the 
infection.  Surgical ablation of the clitoral sinuses may be indicated as a last resort for 
persistently infected mares (APHIS 2009).  In stallions, T. equigenitalis is a surface 
contaminant that does not illicit an inflammatory reaction or identifiable antibody 
response (Timoney 1996).  It has been cultured from the urethral sinus and urethral fossa, 
terminal urethra, external surface of the penis and sheath, and to a lesser extent, pre-
ejaculatory fluid.  There is only one report of the bacteria being isolated at necropsy from 
the testes and various accessory sex glands (Kristula and Smith 2004).  Stallions are 
asymptomatic carriers, and may sometimes be difficult to identify by culture (APHIS 
2009). 
The United States testing and treatment protocol for exposed and/or infected 
stallions and mares is available from the United States Department of Agriculture Animal 
and Plant Health Inspection Services.  Currently, Amies transport medium with charcoal 
is the accepted transport medium for genital swabs, and Eugon agar with 10% chocolated 
horse blood the preferred culture medium (Timoney, Shin et al. 1982).  Swabs should be 
submitted refrigerated (~4-6°C) within 24-48 hours of collection for culture (Timoney, 
Harrington et al. 1978; Duquesne, Pronost et al. 2007).  Isolates must be submitted to 
either National Veterinary Services Laboratories (NVSL) or CEM Approved 
Laboratories depending on the sample being submitted.  
The most widely accepted way of diagnosing CEM is bacteriological culture 
thereby confirming the presence of T. equigenitalis in the mare and the stallion (APHIS 
2008). Culturing the organism facilitates the characterization of the isolates by their 
culture requirements, their anti-microbial sensitivity and their pathogenic and antigenic 
properties.  The polymerase chain reaction (PCR) assay of T. equigenitalis on swabs has 
been reported to provide a comparatively rapid diagnosis, with increased sensitivity 
(Wakeley, Errington et al. 2006; Duquesne, Pronost et al. 2007). Stallions do not mount a 
detectable humoral antibody response to the bacterium; however, complement fixation 
(CF) can be used in mares to confirm a recent exposure to T. equigenitalis.  In mares, 
antibodies can be found as early as 7 days, reaching peak titers around 21 to 45 days after 
infection (Timoney 1996).  Additional serum agglutination tests and antiglobulin tests 
have been used, but complement fixation test reactions are detected for longer periods of 
time post infection compared to the other two tests (Dawson, Benson et al. 1978).   In 
addition, slide agglutination tests and immunofluorescence tests using monoclonal 
antibodies can help confirm culture results (APHIS 2009).   PCR, however, is used as a 
screening test for mares and stallions in conjunction with cultures, and has been shown to 
discriminate between T. equigenitalis and T. asinigenitalis, a genetically closely related 
species found in the genital tract of donkeys and less frequently horses (Wakeley, 
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Errington et al. 2006).  Unlike PCR, the use of latex agglutination tests will not 
differentiate these two strains (APHIS 2008).   
When repeated negative cultures are obtained from quarantined stallions, test 
breedings on CEM negative mares are used to rule out the asymptomatic carrier state 
(APHIS 2009).  It is possible, however, for these test bred mares to test positive on test 
breedings even after the stallion has been cultured negative following treatment.  
Taylorella equigenitalis can be transmitted during both natural breeding and 
artificial insemination, during parturition, as well as indirectly through fomites (Samper 
2007).  Current investigation as to the source of the 2008 isolation of T. equigenitalis in 
Kentucky has failed to identify whence it originated.  Spread of the organism among 
stallions is believed to have been via contaminated phantoms, artificial vaginas, and 
various other AI equipment used during semen collection (personal communication).  
With the increase in shipped semen worldwide, it is critical to develop appropriate semen 
handling and processing techniques to prevent the dissemination of T. equigenitalis.   
Equine semen extenders are widely used and are essential for the proper 
preservation of semen for use in AI.  Semen extenders are utilized to maintain plasma 
membrane integrity while protecting spermatozoa from cold shock, detrimental seminal 
plasma proteins, and toxic byproducts produced by the sperm cells.   In addition, semen 
extenders maintain a neutral pH and osmotic pressure within 250 mOsm/L – 400 
mOsm/L.   Additives may include skim milk or non-fat milk solids, egg yolk, glycerol, 
glucose, Vitamin E, proteinase inhibitors, Methylxanthines, and antibiotics (Katila 1997).  
Most extenders used today contain antibiotics to decrease bacterial growth in semen; 
however, additional antimicrobial supplementation of extender is also accepted.  Initial 
antibiotic trials on semen extenders began in 1978, when AI was proposed as a means to 
control CEM in Thoroughbreds (Timoney, O'Reilly et al. 1978).  At that time, the 
addition of gentamicin to semen extenders proved to be far superior to either ampicillin 
or penicillin in combination with polymyxin to inhibit the growth of T. equigenitalis in 
“spiked” semen.   
 The extenders used in this study include INRA 96®, E-Z Mixin BF®, and 
VMDZ®.   INRA 96® is a common internationally used extender that contains defined 
concentrations of lactose, supplemented with a purified fraction of milk caseins (native 
phosphocaseinate (NPPC)), glucose, Hank’s salts, penicillin, gentamicin and 
amphotericin B (Fayrer-Hosken, Abreu-Barbosa et al. 2008).  INRA 96® is available in 
solution as provided by the manufacturer.  Some extenders, like INRA 96®, can be 
supplemented with antibiotics to help increase the antibiotic strength of the semen 
extender.  Timentin® has recently become an additive in semen extenders across the 
country, and antibiotic susceptibility tests for the recent T. equigenitalis occurrence have 
shown susceptibility to ticarcillin (APHIS 2009).  E-Z Mixin BF®, also known as  “Basic 
4 
 
Formula”, is a skim milk based extender with no antibiotics added that requires mixing 
dry powder with USP purified water.  VMDZ® is a newer, internationally used, egg yolk 
based extender with the antibiotic additives amikacin and potassium penicillin G that 
requires mixing dry powder with sterile water.  
In addition to those mentioned above, there are multiple semen extenders 
containing various antibiotics available on the market today; however, little is known 
about their bactericidal capacity against T. equigenitalis.  Antibiotic susceptibility 
profiles performed on the 2008 T. equigenitalis isolates have shown sensitivity to 
multiple antimicrobials including penicillin, ticarcillin, amikacin, gentamicin, 
tetracycline, silver sulfadiazine, nitrofurantoin, and sulfamethoxazole/trimethoprim in 
various formulations (APHIS 2009). For this reason, we investigated the potential for 
survival of T. equigenitalis in cool-shipped stallion semen inoculated with known 
concentrations of the organism using specific antibiotic containing extenders. 
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CHAPTER II 
 
 
MATERIALS AND METHODS 
 
Sample Collection and Bacteriology 
The first part of this study involved 4 replicates with T. equigenitalis in semen 
extender without the addition of semen.  The following semen extenders were used and 
handled as recommended by the manufacturer: INRA 96®, INRA 96® with 0.5 mg/mL 
Timentin®, INRA 96® with 1.0 mg/mL  Timentin®, INRA 96® with 1.5 mg/mL 
Timentin® , E-Z Mixin BF® “Basic Formula”, and VMDZ®.  Based on the known 
geographic distribution of T. equigenitalis, INRA 96® was chosen as an internationally 
used skim milk based semen extender, and VMDZ® was chosen as an internationally 
used egg-yolk based semen extender.   
Two streptomycin resistant strains of T. equigenitalis, isolated from England in 
the late 1970’s, were used: Both were “type” strains from the National Veterinary 
Services Laboratory (NVSL) maintained at -80°C at the Oklahoma Animal Disease 
Diagnostic Laboratory (OADDL) and University of Missouri Veterinary Diagnostic 
Laboratory respectively; the strain from Missouri was kindly provided to OADDL by Dr. 
William Fales for use in this project. 
A 3.1g vial of Timentin® powder was mixed with 13 mL sterile water to equal 
200 mg/mL ticarcillin (as labeled by the manufacturer).  Once thoroughly mixed, three 
different concentrations (0.5 mg/mL, 1.0 mg/mL, and 1.5 mg/mL) of Timentin® were 
added to 10 mLs of INRA 96®.  Suspensions of T. equigenitalis were made to a 0.5 
MacFarland standard using the nephalometer of the Sensititre™ autoinoculator (Trek 
Diagnostics, Cleveland, OH), and 100 µL of suspension was added to 10 mL aliquots of 
each of the various extenders.   This concentration was chosen because it resulted in 
bacterial growth providing countable colonies routinely in the range of 100-300 colony 
forming units per mL (CFU/mL).  After extender and the suspension of T. equigenitalis 
were mixed, 100 µL of the bacteria/extender preparation was plated onto chocolate 
Eugon agar plates using a spreader at times 0 hrs, 24 hrs, 48 hrs, and 72 hrs (Timoney, 
Shin et al. 1982).  The plates were incubated at 37° C in 7% CO2 for approximately 72 to 
96 hrs, or until CFUs were visible, up to 7 days. The CFU/mL were calculated by 
visually counting individual colonies at 24 hour intervals and recorded as negative if no 
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CFU/mL were observed during the 7 day period.  Colonies were confirmed as T. 
equigenitalis based on colonial morphology, gram-negative stain, positive cytochrome 
oxidase test, and positive catalase reaction.   The extender/semen/bacteria replicates were 
maintained at 4.5 °C between plating to simulate the real life transport conditions of 
chilled/shipped semen samples utilized by the equine industry.                     
  An additional 10 replicates were prepared as the first 4 replicates, with the 
addition of semen from two Oklahoma State University-owned quarter horse stallions (5 
replicates per stallion).  The semen was collected from each stallion using a Missouri 
model artificial vagina and standard semen collection protocols.  Aseptic technique was 
used with each collection and included pre-warmed non-spermicidal sterile lubricant, a 
filter to remove the gel fraction of the ejaculate, pre-warmed collection containers, and 
sterile gloves.   
  The semen was added to each of the 6 semen extenders listed above at a 1:4 ratio 
(semen to extender).  For replicates 5-10, the 3.1g vial of Timentin® powder was mixed, 
according to label, using 13 mL sterile water.  For the last 4 replicates, the 3.1 g vial of 
Timentin® was mixed with 13 mL INRA 96® as supplied by the manufacturer instead.  
The use of INRA 96® was included to ensure that the sterile water was not affecting 
sperm membrane integrity through changes in extender osmolarity.  There was no 
detectable difference between the two solutions on spermatozoa membrane integrity 
(unpublished data).  Lastly, 100 µL of T. equigenitalis suspension was added at the same 
time the semen was added to the extender.  Once each aliquot was prepared, the samples 
were plated as described above.  There were a total of 6 aliquots per stallion per replicate, 
with 10 replicates total.   
 
Statistics  
 
PC SAS Version 9.1 (SAS Institute, Cary, NC) was used for all statistical 
analyses.  The effects of time and treatment on the number of colony forming units were 
assessed with analysis of variance procedures using PROC MIXED.  A repeated 
measures model was used with stallion as the subject and time as the repeated factor.  
The effect of replicate was considered random and all comparisons adjusted for replicate 
to replicate variation.  The simple effects of treatment given time, and time given 
treatment, were assessed with a SLICE option in an LSMEANS statement.  Differences 
were considered significant if the respective p-value was less than or equal to 0.05.  As a 
secondary analysis, the proportion of samples testing positive, and its relationship with 
the factors of interest, was further assessed with contingency tables and Fisher Exact 
Tests.   
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During the experiment, 14 total replicates were performed; however, replicates 5 
and 6 were removed from the statistical analysis due to laboratory error.  In addition, the 
semen sample from replicate 10 was removed from the study due to significant 
overgrowth of bacterial containments.   
For each semen extender, at each particular time period (0, 24, 48, 72 hrs), the results for 
replicates without semen added (replicates 1-4) were averaged with replicates containing 
semen from both stallions (replicates 7- 9 and 11-14).  
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CHAPTER III 
 
 
RESULTS 
 
The results of bacterial growth over time are presented in Tables 1 and 2 and 
further illustrated in Figures 1 and 2.  Table 1 shows the average number of CFU/mL 
decreased significantly over 48 hrs in INRA 96® without Timentin® added (from 90-
3000 CFU/mL at 24 hrs to 0-40 CFU/mL at 48 hrs).  There was no significant decrease in 
the average CFU/mL over time among the other semen extenders tested (Figure 1) 
because the CFU/mL was already dramatically reduced within 24h.   
 Large numbers of T. equigenitalis (≥ 3000 CFU/mL) were consistently isolated 
from replicates of the non-antimicrobial containing extender, E-Z Mixin BF®, at each 
time point (Figure 1). At all time points evaluated, significantly higher numbers of T. 
equigenitalis were isolated from E-Z Mixin BF® compared to the other semen extenders 
evaluated (Table 2; Figure 2).  
At 24 hrs, significantly more CFU/mL were isolated from INRA 96® than either 
VMDZ® or INRA 96® with Timentin® added at any of the three concentrations (Table 
2; Figure2).  There was no significant difference in the number of CFU/mL isolated 
between VMDZ® and INRA 96® with Timentin® added at any concentration (0.5 
mg/mL, 1.0 mg/mL, and 1.5 mg/mL) (Table2; Figure2).  
Additionally, the Fisher’s Exact Test revealed that the effect of time was significant in 
the proportion of incidence of Taylorella equigenitalis, which was isolated (≥1 CFU) 
from INRA 96 100% of the time 0 hrs, 64% of the time at 24 hrs, 18% at 48 hrs, and 9% 
at 72 hrs.
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CHAPTER IV 
 
 
DISCUSSION 
 
 
        Transmission of T. equigenitalis remains a concern for many equine 
practitioners.  The primary burden is the major economic loss as a result of decreased 
fertility and international controls on transport requirements of horses and equine 
germplasm (Samper 2007).  Since the 2008 discovery of T. equigenitalis in Kentucky, 5 
positive mares have been diagnosed and treated.  Of these 5 positive mares, 4 were 
exposed by AI (APHIS 2010).  While T. equigenitalis can be transmitted via cooled 
shipped semen, appropriately selected equine semen extenders can be utilized as a means 
to help decrease the number of exposed mares bred by AI.  However, the question still 
remains as to how well these extenders can decrease the infectivity of T. equigenitalis in 
semen.   
Typically equine semen is cool-shipped overnight, allowing only 24 hrs for 
antibacterial effectiveness.  Because of this, it is important not only for these extenders to 
decrease and/or inhibit bacterial growth, but to do so in a timely manner (~24 hrs).  In 
addition, it was important in our study to simulate this process by preparing our samples 
and then refrigerating them until cultures were made at each time point.  Our results 
indicate that INRA 96® without Timentin® added does significantly decrease the 
bacterial population in semen over 48 hrs, however, it is significantly less effective at 24 
hrs than either VMDZ® as supplied by the manufacturer or INRA 96® with Timentin® 
added at any of the three concentrations used.  
The purpose of using Timentin® in this study was to evaluate its antibacterial 
activity against T. equigenitalis compared to current semen extenders, and to determine 
its mean inhibitory concentration (MIC) against the organism.  The ideal concentration of 
Timentin® to be added to equine semen extenders was not obtained in this study, such 
that no significant difference in bacterial growth was observed by adding 0.5 mg/mL, 1.0 
mg/mL, or 1.5 mg/mL of Timentin® to INRA 96® as supplied by the manufacturer.  
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Further research to find the MIC of Timentin® in INRA 96® is warranted.  In addition, 
further research is necessary to evaluate how these extenders, with the addition of 
Timentin®, affect sperm motility and viability (unpublished data).  It is important, in the 
case of AI, to compare semen extenders based on multiple semen parameters to increase 
longevity of sperm cells, while maximizing fertility and decreasing the spread of 
pathogens.   
In conclusion, this study suggests that using either VMDZ®, as supplied by the 
manufacturer, or INRA 96® with Timentin® added at one of three concentrations (0.5 
mg/mL, 1.0 mg/mL, and 1.5 mg/mL) will reduce the presence of T. equigenitalis in 
semen during equine artificial insemination compared to INRA 96® as supplied by the 
manufacturer or E-Z Mixin BF®.  Furthermore, insemination during the first 24 hours 
post-collection may allow for infectivity of T. equigenitalis if appropriate extenders, such 
as either INRA 96® with Timentin® added or VMDZ® are not added to the semen. 
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Table 1.  ANOVA results for mean CFU/mL of Taylorella equigenitalis isolated in 
INRA 96®.  The data were averaged across all replicates at times 0, 24, 48, and 72 hrs.  
This table shows level of significance between each time point, using INRA 96®, 
denoted as a, b, or c. 
  
Table 1.  Statistical Comparison (in CFU/mL) 
of Taylorella equigenitalis at 0, 24, 48, and 72 
hrs in INRA 96®. 
HOUR 
 
TREATMENT 
MEAN 
 CFU/mL 
STANDARD 
ERROR 
0 INRA 96 2470.91 a 354.925 
24 INRA 96 373.64 b 277.444 
48 INRA 96 6.36 c 4.322 
72 INRA 96         1.82 c 1.818 
14 
 
Table 2. Statistical Comparison (in CFU/mL) of Taylorella 
equigenitalis in 6 Different Equine Semen Extenders at 0, 
24, 48, and 72 hrs. 
HOUR  TREATMENT 
MEAN 
CFU/mL 
STANDARD 
ERROR 
0 E-Z Mixin BF >3000 a 0 
0 INRA 96 2470.91b 354.925 
0 INRA + 0.5mg/ml Timentin 0 c 0 
0 INRA + 1.0mg/ml Timentin 0 c 0 
0 INRA + 1.5mg/ml Timentin 0 c 0 
0 VMDZ 1.82 c 1.818 
    
24 E-Z Mixin BF >3000 a 0 
24 INRA 96 373.64 b 277.444 
24 INRA + 0.5mg/ml Timentin 0 c 0 
24 INRA + 1.0mg/ml Timentin 0 c 0 
24 INRA + 1.5mg/ml Timentin 0 c 0 
24 VMDZ 2.73 c 2.727 
    
48 E-Z Mixin BF >3000 a 0 
48 INRA 96 6.36 b 4.322 
48 INRA + 0.5mg/ml Timentin 18.18 b 18.182 
48 INRA + 1.0mg/ml Timentin 0 b 0 
48 INRA + 1.5mg/ml Timentin 0 b 0 
48 VMDZ 0 b 0 
    
72 E-Z Mixin BF >3000 a 0 
72 INRA 96 1.82 b 1.818 
72 INRA + 0.5mg/ml Timentin 5.45 b 5.455 
72 INRA + 1.0mg/ml Timentin 0 b 0 
72 INRA + 1.5mg/ml Timentin 0 b 0 
72 VMDZ 0.91 b 0.909 
 
Table 2.  ANOVA results for mean CFU/mL of Taylorella equigenitalis isolated in each 
extender used.  The data were averaged across all replicates at times 0, 24, 48, and 72 hrs.  
This table compares level of significance between each of the 6 extenders, at each time 
point, denoted as a, b, or c.   
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Figure 1.  Mean CFU/mL isolated from 6 semen extenders inoculated with Taylorella 
equigenitalis averaged over all replicates.  Trends for each semen extender are illustrated 
over 72 hours.  This figure shows level of significance between each time point for each 
extender used, denoted as a, b, or c. 
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Figure 1. Taylorella equigenitalis Isolated from Equine 
Semen Extender I
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Figure 2.  Mean CFU/mL isolated from 6 semen extenders inoculated with Taylorella 
equigenitalis averaged over all replicates at 0, 24, 48, and 72 hours.  This figure shows 
level of significance between each of the 6 extenders, at each time point, denoted as a, b, 
or c. 
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Figure 2. Taylorella equigenitalis Isolated from Equine 
Semen Extender II
b
a
c   c   c c
a a
b
c   c   c c b  b  b b  b b  b  b b  b
a
(2471 +/- 355 CFU/mL)
(374 +/- 277 CFU/mL)
VITA 
 
Bettina Teresa Olivieri, DVM 
 
Candidate for the Degree of 
 
Master of Science 
 
Thesis:   ANTIMICROBIAL ACTIVITY OF EQUINE SEMEN EXTENDERS 
AGAINST Taylorella equigenitalis 
 
Major Field:  Veterinary Biomedical Sciences 
 
Biographical: 
 
Education: 
 
Completed the requirements for the Master of Science in Veterinary Biomedical 
Sciences at Oklahoma State University, Stillwater, Oklahoma in May 2010. 
 
Completed the requirements for the Doctor of Veterinary Medicine at 
Oklahoma State University, Stillwater, Oklahoma in May 2009. 
 
Completed the requirements for the Bachelor of Science in Integrative Biology 
at University of Florida, Gainesville, Florida in 2005. 
 
Experience:  
Currently working as a Theriogenology Intern at Oklahoma State University 
CVHS Veterinary Hospital.  
 
Professional Memberships:  SFT and AAEP 
 
 
 
 
 
 ADVISER’S APPROVAL:   G. Reed Holyoak, DVM, MS, PhD, DACT 
 
 
 
Name: Bettina Teresa Olivieri                                                   Date of Degree: May, 2010 
 
Institution: Oklahoma State University                      Location: Stillwater, Oklahoma 
 
Title of Study: ANTIMICROBIAL ACTIVITY OF EQUINE SEMEN EXTENDERS 
AGAINST Taylorella equigenitalis  
 
Pages in Study: 16                     Candidate for the Degree of Master of Science 
Major Field: Veterinary Biomedical Sciences 
 
Scope and Method of Study:  
 
Taylorella equigenitalis is a gram negative coccobacillus and the causative agent of a 
transmissible venereal disease in horses known as contagious equine metritis (CEM).   
This disease can be responsible for significant economic loss as a result of decreased 
fertility and increased rigidity of international controls on shipment of horses and equine 
germplasm.  Outbreaks of this disease have been documented in various countries since 
1977, with the most recent discovery of CEM in the United States in December 2008.  
During disease occurrences / outbreaks, culturing semen samples for T. equigenitalis 
prior to breeding may help to prevent transmission of this disease; however, little is 
known about the antimicrobial activity of equine semen extenders against the organism.  
The purpose of this study was to investigate the infectivity levels of T. equigenitalis in 
several equine semen extenders inoculated with known concentrations of the organism.  
The semen extenders used included INRA 96®, E-Z Mixin BF®, and VMDZ®.  In 
addition, Timentin® was added to INRA 96® at three different concentrations (0.5, 1.0, 
and 1.5 mg/mL) to further investigate synergistic effects of antibiotic supplementation to 
extenders.    
 
Findings and Conclusions:   
 
Results were based on visually counting colonies on chocolate Eugon agar plates.   Both 
INRA 96® with added Timentin® and VMDZ® (as supplied by the manufacturer) 
significantly reduced the numbers of T. equigenitalis isolated from semen extenders 
compared to INRA 96® (as supplied by the manufacturer) or the antibiotic free E-Z 
Mixin BF®.  Our findings indicate that INRA 96® with Timentin® added or VMDZ® 
may significantly decrease the growth of T. equigenitalis in extended semen, however, it 
is also important to consider possible effects on sperm longevity and fertility while 
decreasing seminal pathogens. 
 
